$55.98-2.93%
2026-10-06 closeTravere Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $233M. 2024 operating profit was −$324M.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy
Travere Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $233M. 2024 operating profit was −$324M.